Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul 1:152:79-86.
doi: 10.1016/j.drugalcdep.2015.04.016. Epub 2015 Apr 30.

Addiction and treatment experiences among active methamphetamine users recruited from a township community in Cape Town, South Africa: A mixed-methods study

Christina S Meade  1 , Sheri L Towe  2 , Melissa H Watt  3 , Ryan R Lion  4 , Bronwyn Myers  5 , Donald Skinner  6 , Stephen Kimani  7 , Desiree Pieterse  8
Affiliations

Addiction and treatment experiences among active methamphetamine users recruited from a township community in Cape Town, South Africa: A mixed-methods study

Christina S Meade et al. Drug Alcohol Depend. .

Abstract

Background: Since 2000, there has been a dramatic increase in methamphetamine use in South Africa, but little is known about the experiences of out-of-treatment users. This mixed-methods study describes the substance use histories, addiction symptoms, and treatment experiences of a community-recruited sample of methamphetamine users in Cape Town.

Methods: Using respondent driven sampling, 360 methamphetamine users (44% female) completed structured clinical interviews to assess substance abuse and treatment history and computerized surveys to assess drug-related risks. A sub-sample of 30 participants completed in-depth interviews to qualitatively explore experiences with methamphetamine use and drug treatment.

Results: Participants had used methamphetamine for an average of 7.06 years (SD=3.64). They reported using methamphetamine on an average of 23.49 of the past 30 days (SD=8.90); 60% used daily. The majority (90%) met ICD-10 criteria for dependence, and many reported severe social, financial, and legal consequences. While only 10% had ever received drug treatment, 90% reported that they wanted treatment. In the qualitative interviews, participants reported multiple barriers to treatment, including beliefs that treatment is ineffective and relapse is inevitable in their social context. They also identified important motivators, including desires to be drug free and improve family functioning.

Conclusion: This study yields valuable information to more effectively respond to emerging methamphetamine epidemics in South Africa and other low- and middle-income countries. Interventions to increase uptake of evidence-based services must actively seek out drug users and build motivation for treatment, and offer continuing care services to prevent relapse. Community education campaigns are also needed.

Keywords: Addiction; Drug abuse; Methamphetamine; South Africa; Substance abuse treatment.

PubMed Disclaimer

References

    1. Barr AM, Panenka WJ, MacEwan GW, Thornton AE, Lang DJ, Honer WG, Lecomte T. The need for speed: an update on methamphetamine addiction. J. Psychiatry Neurosci. 2006;31:301–313. - PMC - PubMed
    1. Birks M, Chapman Y, Francis K. Memoing in qualitative research: Probing data and processes. J. Res. Nurs. 2008;13:68–75. doi: 10.1177/1744987107081254.
    1. Brecht ML, Herbeck D. Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors. Drug Alcohol Depend. 2014;139:18–25. doi: 10.1016/j.drugalcdep.2014.02.702. - PMC - PubMed
    1. City of Cape Town 2011 Census - Delft Profile. Compiled by Strategic Development Information and GIS Department, City of Cape Town, using 2011 Census data supplied by Statistics South Africa. 2013
    1. Coovadia H, Jewkes R, Barron P, Sanders D, McIntyre D. The health and health system of South Africa: historical roots of current public health challenges. Lancet. 2009;374:817–834. doi: 10.1016/s0140-6736(09)60951-x. - PubMed

Publication types

Substances